Man Group plc Acquires Shares of 60,069 HCA Healthcare, Inc. $HCA

Man Group plc bought a new position in HCA Healthcare, Inc. (NYSE:HCA) in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 60,069 shares of the company’s stock, valued at approximately $23,420,000.

A number of other hedge funds have also recently added to or reduced their stakes in HCA. Palisade Asset Management LLC acquired a new position in shares of HCA Healthcare in the 3rd quarter valued at about $26,000. Ares Financial Consulting LLC bought a new position in HCA Healthcare in the fourth quarter worth about $31,000. Cedar Mountain Advisors LLC bought a new position in shares of HCA Healthcare during the first quarter valued at approximately $33,000. MCF Advisors LLC boosted its position in HCA Healthcare by 213.0% during the 4th quarter. MCF Advisors LLC now owns 72 shares of the company’s stock valued at $34,000 after purchasing an additional 49 shares during the period. Finally, MidFirst Bank acquired a new stake in HCA Healthcare in the second quarter worth $28,000. Institutional investors and hedge funds own 62.73% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts have recently commented on HCA shares. Mizuho lowered their price target on shares of HCA Healthcare from $525.00 to $475.00 and set an “outperform” rating for the company in a research report on Tuesday, July 28th. TD Cowen reduced their target price on shares of HCA Healthcare from $500.00 to $431.00 and set a “buy” rating for the company in a research note on Monday, June 22nd. Robert W. Baird cut their price target on HCA Healthcare from $396.00 to $393.00 and set a “neutral” rating on the stock in a report on Monday, July 27th. Royal Bank Of Canada reissued an “outperform” rating and issued a $435.00 price objective on shares of HCA Healthcare in a report on Monday, July 27th. Finally, Weiss Ratings lowered HCA Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Tuesday, June 9th. Fourteen analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, HCA Healthcare presently has a consensus rating of “Moderate Buy” and an average price target of $462.64.

HCA Healthcare Trading Down 0.6%

Shares of NYSE:HCA opened at $426.36 on Thursday. HCA Healthcare, Inc. has a twelve month low of $353.99 and a twelve month high of $556.52. The firm has a market cap of $92.31 billion, a P/E ratio of 14.27, a P/E/G ratio of 1.49 and a beta of 1.10. The company has a 50 day moving average of $399.36 and a 200-day moving average of $442.21.

HCA Healthcare (NYSE:HCA) last announced its earnings results on Friday, July 24th. The company reported $7.59 EPS for the quarter, topping the consensus estimate of $7.56 by $0.03. The firm had revenue of $20.23 billion for the quarter, compared to analysts’ expectations of $19.76 billion. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%.The firm’s quarterly revenue was up 8.7% compared to the same quarter last year. During the same quarter in the previous year, the company earned $6.84 earnings per share. Equities research analysts forecast that HCA Healthcare, Inc. will post 29.42 EPS for the current year.

HCA Healthcare Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, September 30th. Investors of record on Wednesday, September 16th will be paid a dividend of $0.78 per share. The ex-dividend date of this dividend is Wednesday, September 16th. This represents a $3.12 annualized dividend and a yield of 0.7%. HCA Healthcare’s dividend payout ratio (DPR) is currently 10.45%.

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.